Smartchoices Lanolin Plus
NDC Package 70196-1333-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Smartchoices Lanolin Plus is apply 0.15g once a day.Smooth onto nipple area as needed. Marketed by Florri Feme Pharmaceuticals Ltd, this product is identified by NDC 70196-1333 and is authorized under FDA application part347.

Identification & Billing

NDC Package Code
70196-1333-2
Package Description
2 mg in 1 PACKET
Product Code
11-Digit Billing Format
70196133302

Clinical Specifications

Proprietary Name
Smartchoices Lanolin Plus 0
Dosage Form
-
Usage Information
Apply 0.15g once a day.Smooth onto nipple area as needed

Regulatory & Marketing

Labeler Name
Florri Feme Pharmaceuticals Ltd
FDA Application #
part347
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
10-01-2010
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70196-1333-2 identifies a specific commercial package of 2 mg in 1 packet of Smartchoices Lanolin Plus 0, labeled by Florri Feme Pharmaceuticals Ltd. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Florri Feme Pharmaceuticals Ltd on October 01, 2010. The current certification is valid through December 31, 2017.

How is this Florri Feme Pharmaceuticals Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70196133302. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
70196-1333-2
11-Digit CMS (5-4-2)
70196-1333-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.